+ Watch CNDO
on My Watchlist
In a mood to get more risk on and adopted a number of ZZZZZman's most recent picks in biotech space
For CAPS purposes, I can green thumb Coronado despite the ugly decline in share price since the hysterical bubble peak of 3.2 in January. In real life, I would probably be a little more judicious although it would be quite interesting to see the gap fill all the way back to the 1.3 low from October. The current market cap is 76M and cash is 100M, but the short position is still 23%. A lot of people clearly think this company is pure, unadulterated garbage and after the pig poop worm egg debacle it's hard to disagree. Nevertheless, interesting things do happen to stocks where the market cap is well below cash so I'll be keeping an eye on Coronado for an irrational spike on new pie-in-the-sky PR.
Biotech gamble, down but not out
Nice entry on nice little biotech with a solid pipeline and solid cash position.
Biotech. Big losses. Selling tons of stock.
The company has a smart and experienced executive team with past pharma experiencing getting drugs from the trial to FDA approved stage. It's all a question of if their innovative solutions work as they're supposed to.
This young biotech has a top-notch management team and an exciting roster of drugs entering final stage testing. The drugs are targeting autoimmune diseases and cancer. The most novel is an approach using parasites to activate the immune system. Has potential to be a big winner - buy now while it's still cheap!
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions